ConductScience.org, home

Paper · 1908563

Co-engagement of CD8 with the T cell receptor is required for negative selection.

Ingold AL and 4 others. Nature, 1991. Cited by 83 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Co-engagement of CD8 with the T cell receptor is required for negative selection. Papers, record 1908563. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/1908563

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Co-engagement of CD8 with the T cell receptor is required for negative selection.
PubMed
Journal
Nature
PubMed
Year
1991
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
83
iCite
Relative citation ratio, by iCite
1.22
iCite
Revised in PubMed
2017-11-16
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Ingold ALA L
2Landel CC
3Knall CC
4Evans GAG A
5Potter TAT A

Source PubMed

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antigens, Differentiation, T-LymphocyteMajor topic
Receptors, Antigen, T-CellMajor topic
T-Lymphocytes, CytotoxicMajor topic
Thymus GlandMajor topic
Animals
CD8 Antigens
Cell Survival
Histocompatibility Antigens Class I
Immune Tolerance
Major Histocompatibility Complex
Mice
Mice, Transgenic
Receptor Aggregation
Signal Transduction

Source PubMed

Grants0

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

None in this release.

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References0

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

None in this release.

Cited by17

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 83 citations.

PMIDTitleJournalYearIn PapersSource
23,853,580Rapid perturbation in viremia levels drives increases in functional avidity of HIV-specific CD8 T cells.PLoS Pathog2013https://conductscience.org/library/papers/23853580PubMed
17,938,233A constant affinity threshold for T cell tolerance.J Exp Med2007https://conductscience.org/library/papers/17938233PubMed
11,999,166The role of CD4 in regulating homeostasis of T helper cells.Immunol Res2002https://conductscience.org/library/papers/11999166PubMed
9,539,765Disruption of the CD4-major histocompatibility complex class II interaction blocks the development of CD4(+) T cells in vivo.Proc Natl Acad Sci U S A1998https://conductscience.org/library/papers/9539765PubMed
9,497,484CD4 regulates the efficiency of an endogenous superantigen-induced clonal deletion of TCRV beta 11+ cells in the periphery.Immunology1997https://conductscience.org/library/papers/9497484PubMed
9,091,576Peptide-independent recognition by alloreactive cytotoxic T lymphocytes (CTL).J Exp Med1997https://conductscience.org/library/papers/9091576PubMed
8,920,852Thymocytes can become mature T cells without passing through the CD4+ CD8+, double-positive stage.J Exp Med1996https://conductscience.org/library/papers/8920852PubMed
8,467,804Regulated expression of human CD4 rescues helper T cell development in mice lacking expression of endogenous CD4.EMBO J1993https://conductscience.org/library/papers/8467804PubMed
8,413,295Identification and characterization of an Alu-containing, T-cell-specific enhancer located in the last intron of the human CD8 alpha gene.Mol Cell Biol1993https://conductscience.org/library/papers/8413295PubMed
8,355,705A heterodimer of HEB and an E12-related protein interacts with the CD4 enhancer and regulates its activity in T-cell lines.Mol Cell Biol1993https://conductscience.org/library/papers/8355705PubMed

1 to 10 of 17

See all 17 cited by

Genes0

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

None in this release.

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/1908563

GET https://conductscience.org/api/papers/v1/1908563/authors